Form 4 for GDRX GoodRx Holdings, Inc.

Accepted 2026-05-15 16:50:12 ET · period of report 2026-05-15 · accession 0001809519-26-000114 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-05-15 16:50	2026-05-15	GDRX	McGinnis Christopher A	See Remarks	M - OptEx	—	+44.8K	197.3K	+29%	—
D	2026-05-15 16:50	2026-05-15	GDRX	McGinnis Christopher A	See Remarks	F - Tax	$2.49	-19.7K	177.6K	-10%	-$49.1K
D	2026-05-15 16:50	2026-05-15	GDRX	McGinnis Christopher A	See Remarks	M - OptEx	$0.00	-44.8K	492.6K	-8%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2026-05-15	M	A	44,779	—	197,342	D	—	—	(F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
2	Common	Class A Common Stock	2026-05-15	F	D	19,726	$2.49	177,616	D	—	—
3	Derivative	Restricted Stock Unit	2026-05-15	M	D	44,779	$0.00	492,580	D	— · — to —	44,779 Class A Common Stock	(F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F2) The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. (F2) The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters.